Cas no 6221-01-8 (2,5-Pyridinedicarbaldehyde)
2,5-Pyridinedicarbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- 2,5-Pyridinedicarboxaldehyde
- 2,5-Pyridinedicarbaldehyde
- pyridine-2,5-dicarbaldehyde
- 2,5-二醛基吡啶
- BS-17734
- 6221-01-8
- DTXSID00479434
- YSZC099
- D80964
- AKOS037649272
- 2,5-Pyridine dicarboxaldehyde
- CS-0110533
- SCHEMBL7800455
- DB-134143
-
- MDL: MFCD13175969
- Inchi: 1S/C7H5NO2/c9-4-6-1-2-7(5-10)8-3-6/h1-5H
- InChI Key: GVWYIGSUECJNRM-UHFFFAOYSA-N
- SMILES: O=CC1=CN=C(C=O)C=C1
Computed Properties
- Exact Mass: 135.03205
- Monoisotopic Mass: 135.032028402g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 10
- Rotatable Bond Count: 2
- Complexity: 136
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.1
- Topological Polar Surface Area: 47
Experimental Properties
- PSA: 47.03
2,5-Pyridinedicarbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM523015-250mg |
Pyridine-2,5-dicarbaldehyde |
6221-01-8 | 96%+ | 250mg |
$*** | 2023-05-30 | |
| Chemenu | CM523015-1g |
Pyridine-2,5-dicarbaldehyde |
6221-01-8 | 96%+ | 1g |
$*** | 2023-05-30 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1181173-250mg |
2,5-Pyridine dicarboxaldehyde |
6221-01-8 | 98% | 250mg |
¥734.00 | 2024-05-06 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1181173-1g |
2,5-Pyridine dicarboxaldehyde |
6221-01-8 | 98% | 1g |
¥2306.00 | 2024-05-06 | |
| eNovation Chemicals LLC | Y1199575-1g |
pyridine-2,5-dicarbaldehyde |
6221-01-8 | 95% | 1g |
$800 | 2024-07-23 | |
| Ambeed | A1152395-100mg |
Pyridine-2,5-dicarbaldehyde |
6221-01-8 | 97% | 100mg |
$99.0 | 2025-04-18 | |
| Ambeed | A1152395-250mg |
Pyridine-2,5-dicarbaldehyde |
6221-01-8 | 97% | 250mg |
$120.0 | 2025-04-18 | |
| Ambeed | A1152395-1g |
Pyridine-2,5-dicarbaldehyde |
6221-01-8 | 97% | 1g |
$478.0 | 2025-04-18 | |
| SHANG HAI KAI SHU HUA XUE Technology Co., Ltd. | CL645115-1g |
2,5-Pyridinedicarbaldehyde |
6221-01-8 | 96% | 1g |
¥1500 | 2023-11-08 | |
| Aaron | AR00F479-100mg |
Pyridine-2,5-dicarbaldehyde |
6221-01-8 | 98% | 100mg |
$65.00 | 2025-02-12 |
2,5-Pyridinedicarbaldehyde Suppliers
2,5-Pyridinedicarbaldehyde Related Literature
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
Additional information on 2,5-Pyridinedicarbaldehyde
Introduction to 2,5-Pyridinedicarbaldehyde (CAS No: 6221-01-8)
2,5-Pyridinedicarbaldehyde, with the chemical formula C?H?O? and CAS number 6221-01-8, is a versatile organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This bidentate aldehyde derivative of pyridine exhibits unique structural and functional properties, making it a valuable intermediate in the synthesis of various bioactive molecules. The compound's dual aldehyde functionality allows for facile participation in condensation reactions, including Schiff base formations, which are pivotal in the development of heterocyclic compounds with potential therapeutic applications.
The structure of 2,5-Pyridinedicarbaldehyde features a pyridine core substituted with aldehyde groups at the 2- and 5-positions. This arrangement imparts a high degree of reactivity, enabling its use as a building block in medicinal chemistry. The compound's ability to act as a chelating agent has been explored in the coordination chemistry of transition metals, where it serves as a ligand in the formation of metal complexes with catalytic or pharmaceutical relevance.
In recent years, 2,5-Pyridinedicarbaldehyde has been extensively studied for its role in the synthesis of pharmacologically active agents. One notable area of research involves its application in the development of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with diseases such as cancer. By serving as a precursor for more complex molecules, 2,5-Pyridinedicarbaldehyde contributes to the design of inhibitors that target specific kinase domains, offering potential therapeutic benefits.
Moreover, the compound has found utility in the synthesis of antiviral and antibacterial agents. Its aldehyde groups can undergo Michael addition reactions with nucleophiles such as amines and thiols, leading to the formation of Schiff bases and thiazolidines. These derivatives have shown promising activity against various pathogens due to their ability to disrupt essential biological processes. For instance, studies have demonstrated the efficacy of 2,5-Pyridinedicarbaldehyde-derived Schiff bases in inhibiting viral protease enzymes, which are critical for viral replication.
The synthesis of 2,5-Pyridinedicarbaldehyde typically involves the oxidation of pyridine or its derivatives using strong oxidizing agents such as potassium permanganate or chromium-based oxidants. However, modern synthetic approaches have focused on greener methodologies to minimize environmental impact. Catalytic oxidation using transition metals like ruthenium or manganese has been explored as an alternative route, offering improved selectivity and reduced waste generation.
Recent advancements in computational chemistry have also enhanced our understanding of 2,5-Pyridinedicarbaldehyde's reactivity and interaction with biological targets. Molecular modeling studies have identified key binding pockets on proteins where this compound can dock effectively. These insights have guided the rational design of novel derivatives with enhanced binding affinity and selectivity. For example, computational screening has revealed that modifications at the aldehyde positions can significantly influence binding interactions with target enzymes.
In addition to its applications in drug discovery, 2,5-Pyridinedicarbaldehyde has been utilized in materials science research. Its ability to form coordination complexes with metal ions has led to the development of luminescent materials and sensors. These complexes exhibit tunable emission properties, making them useful in optoelectronic devices and bioimaging applications. Furthermore, the compound's role in catalysis has been explored in organic transformations such as cross-coupling reactions and oxidation processes.
The pharmacokinetic properties of 2,5-Pyridinedicarbaldehyde and its derivatives are also subjects of ongoing research. Understanding how these compounds are absorbed, distributed, metabolized, and excreted is essential for optimizing their therapeutic efficacy. Preclinical studies have begun to investigate the pharmacokinetic profiles of various derivatives to identify those with favorable bioavailability and minimal toxicity.
Future directions in 2,5-Pyridinedicarbaldehyde research may include exploring its potential in gene therapy applications. The compound's ability to form stable complexes with nucleic acids could be leveraged for delivering therapeutic genes or siRNAs into target cells. Additionally, its use in photodynamic therapy has been proposed due to its photosensitizing properties when combined with appropriate photosensitizers.
In conclusion, 2 ,5 - Py rid ine dic arb al de hyde ( C A S N o : 6221 -0 1 -8 ) remains a cornerstone compound in synthetic chemistry and pharmaceutical research due to its unique structural features and diverse applications. Ongoing studies continue to uncover new ways to utilize this versatile intermediate for developing innovative therapeutics across multiple disease areas.
6221-01-8 (2,5-Pyridinedicarbaldehyde) Related Products
- 24014-19-5(1H-Pyrrole-2-carboxaldehyde,4-methyl-)
- 4985-92-6(5-Methylpicolinaldehyde)
- 116785-23-0(4,6-Dimethylnicotinaldehyde)
- 53014-84-9(6-Methylnicotinaldehyde)
- 4663-93-8(2,3-Pyridinedicarboxaldehyde)
- 650141-20-1(2,6-dimethylnicotinaldehyde)
- 780800-85-3(5-Phenylpyridine-2-carbaldehyde)
- 55589-47-4(3-methyl-pyridine-2-carbaldehy)
- 6220-65-1(Pyridine-2,4-dicarbaldehyde)
- 60032-57-7(2-methylpyridine-3-carboxaldehyde)